<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors present a case of severe electrolyte and acid-base disturbances after administration of sorbitol </plain></SENT>
<SENT sid="1" pm="."><plain>The rate of sorbitol infusion was in excess of the stated maximum safe infusion rate in parenteral nutrition </plain></SENT>
<SENT sid="2" pm="."><plain>Sorbitol was used for treating <z:e sem="disease" ids="C0151740" disease_type="Disease or Syndrome" abbrv="">raised intracranial pressure</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The mechanisms of sorbitol metabolism leading to hyperlactacemia, <z:hpo ids='HP_0003128'>lactic acidosis</z:hpo>, <z:hpo ids='HP_0002149'>hyperuricemia</z:hpo>, <z:mpath ids='MPATH_63'>depletion</z:mpath> of intracellular ATP and <z:chebi fb="13" ids="16761">ADP</z:chebi> and <z:mpath ids='MPATH_63'>depletion</z:mpath> of inorganic phosphates are described </plain></SENT>
</text></document>